首页 › 基金 › DODGE & COX › GSK
DODGE & COX 对 GSK 的持仓历史
GSK PLC · 医疗保健
DODGE & COX 在 Q3 2026 的 13F 申报中披露持有 GSK(GSK PLC)43,183,117 股,市值约 US$2.08B,约占其申报组合的 1.12%,在其申报持仓中市值排名第 33 位。 DODGE & COX 最近 13 个申报季度中有 13 个季度披露了 GSK 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
DODGE & COX 对 GSK 的持仓演变
DODGE & COX 于 Q3 2023 首次披露 GSK 持仓:69,281,183 股(约 US$2.51B)。 该持仓在 Q3 2025 达到峰值 78,403,734 股,市值约 US$3.38B。 在 13 次申报中,DODGE & COX 2 次增持、5 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 43,183,117 股、市值约 US$2.08B,环比减持 -5,014,397 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 69.28M | $2.51B | 新进 |
| Q4 2023 | 69.03M | $2.56B | 持有 |
| Q1 2024 | 68.86M | $2.95B | 持有 |
| Q2 2024 | 68.34M | $2.63B | 减持 |
| Q3 2024 | 68.09M | $2.78B | 持有 |
| Q4 2024 | 68.44M | $2.31B | 增持 |
| Q1 2025 | 78.65M | $3.05B | 增持 |
| Q2 2025 | 78.76M | $3.02B | 持有 |
| Q3 2025 | 78.40M | $3.38B | 持有 |
| Q4 2025 | 68.52M | $3.36B | 减持 |
| Q1 2026 | 58.66M | $3.24B | 减持 |
| Q2 2026 | 48.20M | $2.53B | 减持 |
| Q3 2026 | 43.18M | $2.08B | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GSK 与 13F 数据
GSK(GSK PLC)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 GSK,申报仓位最大的包括:Dodge & Cox (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B), JTC Employer Solutions Trustee Ltd (US$389.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GSK 的基金
- Dodge & Cox 48.20M 股 · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.19M 股 · $1.21B · Q3 2026
- JTC Employer Solutions Trustee Ltd 8.08M 股 · $389.17M · Q3 2026
- Mondrian Investment Partners LTD 4.97M 股 · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.92M 股 · $188.73M · Q3 2026
- EQUITY INVESTMENT CORP 3.56M 股 · $171.52M · Q3 2026
更多关于 DODGE & COX
常见问题
How long has DODGE & COX held GSK?
DODGE & COX has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DODGE & COX's current position in GSK?
As of Q3 2026, DODGE & COX holds 43.18M shares of GSK (GSK PLC), valued at $2.08B, representing 1.12% of its reported portfolio and ranking #33.
Has DODGE & COX been buying or selling GSK?
In the latest 13F filing (Q3 2026), DODGE & COX reduced its position in GSK. The position peaked in Q3 2025 at 78.40M shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, JTC Employer Solutions Trustee Ltd, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.